Fiocruz: Brazilian Covid-19 Vaccine Could Advance to Clinical Trials in 2021

RIO DE JANEIRO, BRAZIL - While preparing to produce the Covid-19 vaccine developed by AstraZeneca Pharmaceutical Company and Oxford University, the Oswaldo Cruz Foundation (

To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed? Login Here